Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis

A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.

NCT01817556 ·Status: COMPLETED ·Phase: PHASE4

Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients

NCT02386007 ·Status: UNKNOWN ·Phase: PHASE2

To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients

NCT03443804 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet

NCT03437785 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis

NCT06668506 ·Status: COMPLETED

Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis

NCT06948487 ·Status: RECRUITING

Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients

NCT02691637 ·Status: COMPLETED

Effect of Gastrogenic Microbiota in FD

NCT06760897 ·Status: COMPLETED ·Phase: NA

Trimebutine on the Development of Adverse Events Related to the Helicobacter Pylori Eradication Medications

NCT04403087 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis

NCT04341454 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Hizikia Fusiformis Extract in Subjects Showing Erosive Gastritis

NCT01689701 ·Status: COMPLETED ·Phase: NA

Helicobacter Pylori Gastritis and Its Relation to Metabolic Syndrome Components

NCT06935955 ·Status: NOT_YET_RECRUITING

A Study to Evaluate the Efficacy Between Helicobacter Pylori Eradication Therapy and Motilitone in Functional Dyspepsia

NCT02162316 ·Status: UNKNOWN ·Phase: NA

Clinical Study to Evaluate the Efficacy and the Safety of Eradication Therapy for Helicobacter Pylori in Functional Dyspepsia

NCT00990405 ·Status: UNKNOWN ·Phase: PHASE4

Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population

NCT02112214 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Effect of PPI Therapy on the Result of Helicobacter Pylori Diagnostic Tests

NCT01278901 ·Status: UNKNOWN

Treatment of Atrophic Gastritis After HP Eradication With Modified Liujunzi Decoction Based on Syndrome Differentiation

NCT05388890 ·Status: RECRUITING

Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis

NCT05808010 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia

NCT03024086 ·Status: COMPLETED ·Phase: PHASE3

Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication

NCT01678027 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Long-term Follow-up of Interleukin-1B and H+,K+-ATPase mRNA Expression After Helicobacter Pylori Eradication

NCT04037904 ·Status: COMPLETED

Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method

NCT02151708 ·Status: UNKNOWN ·Phase: NA

Additive Effect of Endonase on Eradication Rate of First Line Therapy for Helicobacter Pylori

NCT01645761 ·Status: COMPLETED ·Phase: NA

The Associations Between the Gastric Mucosal Pathology and the Eradication Rate of H.Pylori :A Multicenter Study

NCT04030715 ·Status: UNKNOWN ·Phase: NA

Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia

NCT06610760 ·Status: RECRUITING ·Phase: PHASE4